ENZY logo

Enzymatica AB (publ) Stock Price

OM:ENZY Community·SEK 472.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

ENZY Share Price Performance

SEK 1.95
0.41 (26.30%)
SEK 1.95
0.41 (26.30%)
Price SEK 1.95

ENZY Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
0 Rewards

Enzymatica AB (publ) Key Details

SEK 53.9m

Revenue

SEK 20.8m

Cost of Revenue

SEK 33.1m

Gross Profit

SEK 85.0m

Other Expenses

-SEK 51.9m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 14, 2026
-0.21
61.45%
-96.27%
0.006%
View Full Analysis

About ENZY

Founded
2007
Employees
20
CEO
Sana Alajmovic
WebsiteView website
www.enzymatica.com

Enzymatica AB (publ), a life science company, develops and sells medical devices for infection-related diseases. The company’s product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care. The company was incorporated in 2007 and is headquartered in Lund, Sweden.

Recent ENZY News & Updates

Recent updates

No updates